two crystalline forms of pinocembrin of formula : α and β , their preparation and their use for manufacture of pharmaceutical compositions . there exists difference between them in bioavailability . they are used for treating and preventing cerebral ischemic diseases by protective action of neurovascular unit , and enhancing blood drug level in vivo .